Biogen Inc 405 Bond Current Valuation
| 09062XAF0 | 99.39 0.11 0.11% |
Valuation analysis of BIOGEN INC 405 helps investors to measure BIOGEN's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that BIOGEN's price fluctuation is very steady at this time. Calculation of the real value of BIOGEN INC 405 is based on 3 months time horizon. Increasing BIOGEN's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BIOGEN is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BIOGEN Bond. However, BIOGEN's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 99.39 | Real 98.71 | Hype 99.39 | Naive 98.94 |
The real value of BIOGEN Bond, also known as its intrinsic value, is the underlying worth of BIOGEN INC 405 Corporate Bond, which is reflected in its stock price. It is based on BIOGEN's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BIOGEN's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of BIOGEN INC 405 helps investors to forecast how BIOGEN bond's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BIOGEN more accurately as focusing exclusively on BIOGEN's fundamentals will not take into account other important factors: BIOGEN INC 405 Corporate Bond Current Valuation Analysis
BIOGEN's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, BIOGEN INC 405 has a Current Valuation of 0.0. This indicator is about the same for the Manufacturing average (which is currently at 0.0) sector and about the same as Industrial (which currently averages 0.0) industry. This indicator is about the same for all United States bonds average (which is currently at 0.0).
BIOGEN Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIOGEN's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the bonds which would be a good addition to a portfolio. Peer analysis of BIOGEN could also be used in its relative valuation, which is a method of valuing BIOGEN by comparing valuation metrics of similar companies.BIOGEN INC cannot be rated in Current Valuation category at this point.
About BIOGEN Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIOGEN INC 405's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIOGEN using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIOGEN INC 405 based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BIOGEN Bond
BIOGEN financial ratios help investors to determine whether BIOGEN Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIOGEN with respect to the benefits of owning BIOGEN security.